Navigation Links
Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target

p>

CONTACT: Media, An Phan, +1-609-558-0420, or +1-609-987-4893, orInvestors, Christian Qvist Frandsen, +1-609-919-7937, both of Novo Nordisk

Web site: http://novonordisk.com/

Ticker Symbol: (:NVO)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:10/7/2008)...VYVANSE taken once-daily significantly,improved th... Oct. 7 /- Shire plc (LSE: ...aceutical company, today,announced that a study pu...linical Psychiatry found once-daily VYVANSE signif...isorder (ADHD) symptoms in adults within,the first...
(Date:10/7/2008)...swire/ -- Aerovance Inc. today reported,pharmacoki... its Aerovant,inhalation powder that demonstrate g...cy following asthma patients, inhalation of a sing...st of three doses investigated in,Aerovance,s Phas...gin early,next year. Evidence gathered from noncli...
(Date:10/7/2008)...ed in Stage A of Trial Assessing Regimen of Bav...taxel -, TUSTIN, Calif., Oct. 7 /PRNewswire-First... PPHM ), a clinical stage biopharmaceutical,compan...nt of cancer and,hepatitis C virus (HCV) infection... in the first stage of a Phase II trial of bavitux...
(Date:10/6/2008)...wire-FirstCall/ -- Pharmasset, Inc.,(Nasdaq: VRUS...ining the,Company as Vice President of Investor Re...ll be responsible for all investor relations,funct...fficer Kurt,Leutzinger., Most recently, Dr. Smith...lyst at JPMorgan Securities, and has been an analy...
Breaking Medicine Technology:Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3CSIRO enlisted to avert global wheat supply crisis 4432 1CSIRO enlisted to avert global wheat supply crisis 4432 2Oregon Based First Pacific Corporation Launches New Integrated 3 D Charting Program for Dentists 25343 1Oregon Based First Pacific Corporation Launches New Integrated 3 D Charting Program for Dentists 25343 2Resolution Health Introduces Womens Health and Wellness Action Campaign 25340 1Resolution Health Introduces Womens Health and Wellness Action Campaign 25340 2Resolution Health Introduces Womens Health and Wellness Action Campaign 25340 3Resolution Health Introduces Womens Health and Wellness Action Campaign 25340 4Tiny molecule helps control blood vessel development UT Southwestern researchers find 25337 1Tiny molecule helps control blood vessel development UT Southwestern researchers find 25337 2
... 23, 2007 /PRNewswire/ -- Researchers at,the Medic...ced the,results of a two-year study, which tested ...s Nerve Stimulation),Therapy(TM) in patients with ...f which Mark S. George, M.D., MUSC Distinguished,P...s is a lead,author, will appear in the April 2007 ...
...enchymal cells in bone marrow supply,leukemic cell...ritical nutrient when it is depleted by the cancer... /PRNewswire/ -- The cancer drug,asparaginase fail...tic leukemia (ALL) because molecules released by c...ect of that drug,according to investigators at St...
Other Medicine Technology:MUSC Research Offers Hope for Those Resistant to Depression,Treatment 2Leukemic Cells Find Safe Haven in Bone Marrow 2Leukemic Cells Find Safe Haven in Bone Marrow 3
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...as good at beating mild to moderate depression as ... comparing five different exercise programs for pe... 50-percent reduction in depressive symptoms amon... like walking on a treadmill three to five times a...
...likely to kill high-risk women compared to women w...ased on findings of a recent study . 8,353 women w...risk because of diabetes or multiple risk factors ...r three years to determine how doctors managed the...
...rchers say girls are affected more than boys. Rese...ifference between girls and boys being diagnosed w...s of conducting a study which aims to establish wh...hy. The study included 307 healthy children 4 or 5...
...to a treatment regimen already consisting of chemo... survival outcomes among women with high-risk brea...udy done between 1979 and 1986, 318 patients were ...herapy or no radiation at all. In a 20-year follow...
Other Medicine News:
Designed to insert eye spheres using spring loaded plunger. Polished finish. Overall length: 125 mm, 4.9 inches.
Size: Large. 24.50 mm by 26.00 mm. Clear lucite. Supplied sterile.
Size: 2.3 x 6.4 x 80 mm. Storz offers the original Scleral Sponge II line designed by Harvey A. Lincoff, M.D. The material is a closed cell sponge which is non-toxic and non-antigenic. Implants are
Size: 5.0 x 80 mm. Storz offers the original Scleral Sponge II line designed by Harvey A. Lincoff, M.D. The material is a closed cell sponge which is non-toxic and non-antigenic. Implants are soft wi
Medicine Products: